IL1A and inflammatory bowel disease: Excessive IL-1/Th17 signaling results in numerous diseases including asthma, chronic obstructive pulmonary disease (Gurczynski and Moore, 2018), inflammatory bowel disease (IBD), and psoriasis (Beringer et al., 2016).